TRUP in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with TRUP today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Trupanion helps pet owners cover veterinary treatment costs in the United States, Canada and parts of continental Europe. Most revenue comes from its subscription business, primarily insurance premiums paid by pet owners. It sets premiums according to each pet’s characteristics and chosen coverage, and pays covered veterinary bills. At hospitals using its direct-payment software, Trupanion can pay approved bills directly, leaving owners to pay only their deductible or co-payment for covered treatment. Veterinary referrals are its largest source of new members.
Trupanion also earns a substantial share of revenue by underwriting insurance sold by other companies. This business depends heavily on Pets Best and has much lower margins than the subscription business. Pets Best is moving policies to other insurers, and Trupanion expects that relationship to shrink and eventually end.
The core business depends on attracting and retaining pet owners while setting premiums that cover veterinary bills and operating costs. Most U.S. states require regulatory approval before Trupanion introduces products or raises prices, which can limit how quickly premiums adjust to costs. Its insurance subsidiaries must also retain required capital, restricting the funds available for growth and general operations.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Trupanion’s results hinge on subscription enrollment and premiums keeping pace with veterinary bills, while Pets Best’s move to other underwriters shrinks Trupanion’s lower-margin third-party business.
Lemonade competes with Trupanion for pet owners’ insurance premiums, and both pay claims for veterinary care. Watch Lemonade’s pet-insurance enrollment and claims costs for signs of competition for customers and pressure from veterinary bills.
Fed Interest Rate Decision
The Fed’s decision on its benchmark interest rate matters to Trupanion because higher rates can raise interest costs on its SOFR-linked loans, leaving less cash for operations and growth.
Expected4.0%Last release4.0%
If it comes in above expectations
Higher-than-expected rates can increase interest expense on Trupanion’s SOFR-linked borrowings, leaving less cash to fund operations and growth.
If it comes in below expectations
Lower-than-expected rates can ease interest costs on Trupanion’s SOFR-linked borrowings, leaving more cash available for operations and growth.
Lemonade, Inc. earningsLMND
Lemonade’s report will show how pet-insurance enrollment and veterinary claims costs are changing in the market where it competes with Trupanion for customers and pays the same kind of bills.
Read Lemonade’s pet-insurance enrollment alongside its claims costs. Enrollment growth without faster-rising claims costs would suggest it is winning pet owners without facing worsening veterinary-bill pressure, easing the competitive and cost signals for Trupanion. Slower enrollment or rising claims costs would point to tougher competition for customers or bills squeezing both insurers.
Trupanion, Inc. earningsThis company
Trupanion’s report will show whether its pet-insurance subscriptions bring in enough revenue from enrolled pets to cover veterinary claims and the cost of acquiring new members.
Read subscription pet enrollment and monthly revenue per pet alongside subscription cost of revenue as a share of revenue. More pets and higher revenue per pet with a lower cost share would show the segment is scaling without veterinary bills consuming more of its revenue; weaker enrollment or revenue per pet with a rising cost share would point to pressure from acquisition, retention or claims. Together, they show whether subscription growth is building a stronger business or squeezing its higher-margin engine.